Cullinan Oncology
CGEM
CGEM
99 hedge funds and large institutions have $467M invested in Cullinan Oncology in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1% less capital invested
Capital invested by funds: $473M → $467M (-$6.62M)
2.74% less ownership
Funds ownership: 83.91% → 81.18% (-2.7%)
Holders
99
Holding in Top 10
4
Calls
$504K
Puts
$2K
Top Buyers
| 1 | +$8.15M | |
| 2 | +$3.54M | |
| 3 | +$2.63M | |
| 4 |
Goldman Sachs
New York
|
+$2.18M |
| 5 |
BlackRock
New York
|
+$1.93M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$10.5M | |
| 3 | -$2.32M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.8M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.25M |